Xiao-Dong Jiao
Overview
Explore the profile of Xiao-Dong Jiao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jiao X, Liu K, Qin B, Wu Y, Lin M, Liu J, et al.
JCO Precis Oncol
. 2022 Feb;
3:1-4.
PMID: 35100720
No abstract available.
12.
Wang Z, Qin B, Ye C, Wang M, Yuan L, Dai W, et al.
Eur J Cancer
. 2022 Jan;
163:152-162.
PMID: 35074651
Background: Current therapeutic regimens for patients with v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E-mutated colorectal cancer show unsatisfactory efficacy. To improve outcomes in this area, we assessed the...
13.
Jiao X, Ding L, Zhang C, Qin B, Liu K, Jiang L, et al.
Transl Lung Cancer Res
. 2021 Aug;
10(7):3236-3250.
PMID: 34430361
Background: The concordance between mutations detected from plasma and tissue is critical for treatment choices of patients with advanced lung adenocarcinoma. Methods: We prospectively analyzed the association of the serum...
14.
Qin B, Jiao X, Zhou X, Shi B, Wang J, Liu K, et al.
Oncoimmunology
. 2021 Aug;
10(1):1929727.
PMID: 34350061
Background: The present study aimed to evaluate the effects of concomitant proton pump inhibitor (PPI) use on immune checkpoint inhibitor (ICI) efficacy among advanced cancer patients. Methods And Materials: A...
15.
He X, Jiao X, Liu K, Qin B, Wu Y, Ling Y, et al.
JCO Precis Oncol
. 2021 May;
5.
PMID: 34036227
No abstract available.
16.
Jiao X, Liu K, Wu Y, Zhou X, Qin B, Ling Y, et al.
Oncologist
. 2021 Apr;
26(9):717-721.
PMID: 33896090
The addition of trastuzumab to chemotherapy regimen is the standard of care for human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer; however, most patients eventually acquire trastuzumab resistance....
17.
Qin W, Wu Y, Liu J, Qin B, Liu K, Jiao X, et al.
Gland Surg
. 2021 Apr;
10(3):1029-1037.
PMID: 33842247
Background: Primary squamous cell carcinoma of pancreas (SCCP) is an extremely rare pathological subtype of pancreatic cancer of ductal origin. Due to its rarity, most previous studies on SCCP focused...
18.
Jiao X, Liu K, Xu M, Yu G, Liu D, Huang T, et al.
Oncologist
. 2020 Sep;
26(4):e524-e529.
PMID: 32997436
This article reports a case of advanced metastatic low-grade sarcoma. The patient was diagnosed with an inoperable large (14 × 12 cm) lesion on his neck in September 2015 and...
19.
Jiao X, Zhang X, Qin B, Liu D, Liu L, Ni J, et al.
Ann Transl Med
. 2020 Aug;
8(14):860.
PMID: 32793704
Background: Tumor mutation burden (TMB) has an important association with immunotherapy responses. TMB in the Chinese population has not been well established. Finding differences between the Chinese and Caucasian populations...
20.
Guo J, Jiao X, Wu Y, Qin B, Liu K, Zang Y
Onco Targets Ther
. 2020 Aug;
13:6289-6293.
PMID: 32753879
Background: Previous studies have suggested the efficacy of HER2 antibody (trastuzumab) in scrotal Paget's disease with HER2 amplification or overexpression. However, no report about the effectiveness of HER2 inhibitor (pyrotinib)...